# Tonix (TNXP) — News

TNXP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tnxp/news

## Recent headlines

- [Monkeypox stocks rose in regular trading, with TNXP up 6.8%, GILD gaining 2.5% and VTRS rising 1.9%.](https://www.ainvest.com/news/monkeypox-stocks-rose-regular-trading-tnxp-6-8-gild-gaining-2-5-vtrs-rising-1-9-2610-64) — AInvest Wire, Oct 14, 2026
  On October 14, 2026, shares of companies associated with monkeypox treatments and vaccines rose in regular trading. Tonix Pharmaceuticals Holding Corp (TNXP) gained 6.8%, while Gilead Sciences (GILD) rose 2.5%, and Verrica Pharmaceuticals (VTRS) increased by 1.9%. The uptick in stock prices…
- [Monkeypox stocks fell in intraday trading, with INO down 9.0%, TNXP falling 3.5% and VRAX sliding 2.7%.](https://www.ainvest.com/news/monkeypox-stocks-fell-intraday-trading-ino-9-0-tnxp-falling-3-5-vrax-sliding-2-7-2610-52) — AInvest Wire, Oct 13, 2026
- [Freshworks Inc: Freshworks to extend FreshService into AI, software spend governance with pact to buy Torii](https://www.ainvest.com/news/freshworks-freshworks-extend-freshservice-ai-software-spend-governance-pact-buy-torii-2610) — AInvest Wire, Oct 12, 2026
- [Tonix Pharmaceuticals: Co intends to enforce Tonmya intellectual property rights - SEC filing](https://www.ainvest.com/news/tonix-pharmaceuticals-intends-enforce-tonmya-intellectual-property-rights-sec-filing-2610) — AInvest Wire, Oct 2, 2026
- [Tonix Pharmaceuticals: Paragraph IV certification challenges four Tonmya patents listed in FDA Orange Book - SEC filing](https://www.ainvest.com/news/tonix-pharmaceuticals-paragraph-iv-certification-challenges-tonmya-patents-listed-fda-orange-book-sec-filing-2610) — AInvest Wire, Oct 2, 2026
  Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) faces legal challenges as a generic drug manufacturer files a Paragraph IV certification challenging four patents listed in the FDA Orange Book for Tonmya, the company’s FDA-approved treatment for major depressive disorder. The certification,…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).